2
Figure 3: Process fingerprint monitoring of a bio-reactor Biopharm production methods need effective real-time monitoring and control to guarantee a low-cost, safe and high quality production. Modern multidisciplinary concepts are the key to effective manufacturing in biotechnology, allowing real-time product release. IPD Process Analytics Process Automation Process Modelling MES New production methods and the market demand for faster development of production processes (shorter time to market) imply a need for a better understanding of the process. The increased emphasis on production efficiency (shortening of throughput delays, up scaling, shift from batch to continuous production methods, increased capacity and yield) needs real- time process information. On the other hand, product safety methodologies result in an increased need for track of product quality throughout the manufacturing process. Also the FDA (Food and Drug Administration) is encouraging a more risk-based and science-based approach instead of current empiric production methods. The FDA’s PAT (Process Analytic Technologies) initiative is one of the current focus topics. Figure 1: Multidisciplinary approach to Bio-reactor optimisation N IR Spectroscopy: composition,Biologic perform ance,... M ass Spectroscopy: composition,... P roduct O ffgas Medium / S ubstrate B uffer/Acid /Lye Air/O 2 /CO 2 B ioreactor Innoculum M N IR Spectroscopy: composition,Biologic perform ance,... N IR Spectroscopy: composition,Biologic perform ance,... M ass Spectroscopy: composition,... M ass Spectroscopy: composition,... P roduct O ffgas Medium / S ubstrate B uffer/Acid /Lye Air/O 2 /CO 2 B ioreactor Innoculum M P roduct O ffgas Medium / S ubstrate B uffer/Acid /Lye Air/O 2 /CO 2 B ioreactor Innoculum P roduct O ffgas Medium / S ubstrate B uffer/Acid /Lye Air/O 2 /CO 2 B ioreactor Innoculum M Improving the process begins with monitoring the process and building awareness on the typical behaviour. For the bio-pharm API production chain, the key process step to monitor is the bio-reactor. Process analytic technologies (PAT) act as the “eyes” inside the bio-reactor. In bioreactor-processes the need for real-time process information is particularly high due to the complexity and unpredictability of the process. Recent PAT developments allow instantaneous in- line measurements (of the liquid and gaseous bio-reactor phase) to get a whole picture or fingerprint of the process. The use of PAT for both physical and chemical status monitoring and also for biological or performance monitoring, is a big step forward in improving process understanding and allowing process optimisation. Information on individual parameters (physical, chemical and biological), the so-called absolute values and also relative measurements, as a measure of change, gives total quality information on the process. These developments provide a holistic view on the process and give better insights into what exactly is happening during the bioreactor process. These tools speed decisions on the batch endpoint, quality or efficiency of a certain process stage. New sensor technologies and also new approaches which can handle a wider range of process parameters allow strict control of operational conditions throughout the bio-pharm process. PAT closes the information gap for defining better control strategies and ultimately optimise the whole process Figure 2: Bioreactor Process Analytical Technologies (PAT) Star t End

Figure 3: Process fingerprint monitoring of a bio-reactor

  • Upload
    bryant

  • View
    31

  • Download
    0

Embed Size (px)

DESCRIPTION

Process Modelling. IPD. MES. Process Analytics. Process Automation. Start. End. bioreactor. optimization. - PowerPoint PPT Presentation

Citation preview

Page 1: Figure 3: Process fingerprint monitoring of a bio-reactor

Figure 3: Process fingerprint monitoring of a bio-reactor

Biopharm production methods need effective real-time

monitoring and control to guarantee a low-cost, safe

and high quality production. Modern multidisciplinary

concepts are the key to effective manufacturing in

biotechnology, allowing real-time product release.

IPD

Process Analytics

Process Automation

ProcessModelling

MES

New production methods and the market demand for faster development of production processes (shorter time to market) imply a need for a better understanding of the process. The increased emphasis on production efficiency (shortening of throughput delays, up scaling, shift from batch to continuous production methods, increased capacity and yield) needs real-time process information. On the other hand, product safety methodologies result in an increased need for track of product quality throughout the manufacturing process. Also the FDA (Food and Drug Administration) is encouraging a more risk-based and science-based approach instead of current empiric production methods. The FDA’s PAT (Process Analytic Technologies) initiative is one of the current focus topics.

Figure 1: Multidisciplinary approach to Bio-reactor optimisation

NIR Spectroscopy:composition, Biologic

performance, ...

Mass Spectroscopy:composition, ...

Product

Off gas

Medium/Substrate

Buffer/Acid /Lye

Air/O2/CO2

BioreactorInnoculum

MM

NIR Spectroscopy:composition, Biologic

performance, ...

NIR Spectroscopy:composition, Biologic

performance, ...

Mass Spectroscopy:composition, ...

Mass Spectroscopy:composition, ...

Product

Off gas

Medium/Substrate

Buffer/Acid /Lye

Air/O2/CO2

BioreactorInnoculum

MM

Product

Off gas

Medium/Substrate

Buffer/Acid /Lye

Air/O2/CO2

BioreactorInnoculum

Product

Off gas

Medium/Substrate

Buffer/Acid /Lye

Air/O2/CO2

BioreactorInnoculum

MM

Improving the process begins with monitoring the process and building awareness on the typical behaviour. For the bio-pharm API production chain, the key process step to monitor is the bio-reactor. Process analytic technologies (PAT) act as the “eyes” inside the bio-reactor. In bioreactor-processes the need for real-time process information is particularly high due to the complexity and unpredictability of the process. Recent PAT developments allow instantaneous in-line measurements (of the liquid and gaseous bio-reactor phase) to get a whole picture or fingerprint of the process.

The use of PAT for both physical and chemical status monitoring and also for biological or performance monitoring, is a big step forward in improving process understanding and allowing process optimisation. Information on individual parameters (physical, chemical and biological), the so-called absolute values and also relative measurements, as a measure of change, gives total quality information on the process. These developments provide a holistic view on the process and give better insights into what exactly is happening during the bioreactor process.These tools speed decisions on the batch endpoint, quality or efficiency of a certain process stage. New sensor technologies and also new approaches which can handle a wider range of process parameters allow strict control of operational conditions throughout the bio-pharm process. PAT closes the information gap for defining better control strategies and ultimately optimise the whole process

Figure 2: Bioreactor Process Analytical Technologies (PAT)

Start

End

Page 2: Figure 3: Process fingerprint monitoring of a bio-reactor

Figure 5: Process Control Strategy for Real Time product release

Figure 6: Overview of the bio-reactor optimisation and real-time product release concept

For more info, please contact:Siemens – RHQ Pharma & Fine Chemicals+32 3 735 0600e-mail [email protected] Or visit us at www.siemens.com/pharma

Product

M

Bioreactor

Conventional control methods

Process Kinetics

Process Optimization

Advanced Process Control

Process Data

Analysis

Process Modeling

Advanced Control methods

Product

M

Bioreactor

Product

M

Bioreactor

Conventional control methods

Process Kinetics

Process Optimization

Advanced Process Control

Process Data

Analysis

Process Modeling

Advanced Control methods

Figure 4: Methodology for Advanced Process Control (APC) of Bio-reactor processes

However, to improve the control of the bio-reactor, a number of physical and chemical parameters must be continuously monitored. Previously, substrate and nutrient contents, metabolite formation and bio-mass concentration were obtained through off-line laboratory methods. Results are not obtained until several hours after sampling and results are fed into the process computer off-line. This markedly limits the possibility of controlling and optimising bioreactor processes.

The integrated Advanced Process Control solution for bioprocess

control which Siemens has developed as part of the Life Science

Solution consists of APC Tools integrated into the Simatic PCS 7

process control system. These tools are interfaced via an OPC client

channel to the WinCC server, and make use of the SCADA database

(Historian) and data obtained by the used Process Analysers. APC

therefore represents an important link between the planning and

scheduling functions of the execution level and control functions. By

using APC, Simatic PCS7 is expanded by a powerful process

optimisation function and ensures not only a more efficient process

control but also greater transparency in production leading to shorter

batch runs and increased quality consistency.Consistency in quality is an important condition for Real-time product release / Parametric release.   

IT / MES INFRASTRUCTURE

PAT application

control modules

electronic batch record

equipment modules

pharma modules

batch

modeling / verification

parametric release

(grey) modeling

control solution

(metabolic) modeling

optimization

1101001001

1001000100

100101111 100111010

1

New process monitoring tools (PAT), new control structures and advanced process control result in an integrated concept for a “transparent” bioreactor.These multidisciplinary tools are the key to ...   ...quickly gain knowledge about the key variables of their particular process   ...find out how to minimise by-products (for a simpler downstream processing) and maximise product yield  ...have a high process reproducibility (consistent quality) and early identification of unsuccessful batches …control even delicate processes 24 hours a day and meet future FDA requirements for real-time product release and a science-based risk approach

Conclusion

Process output

Temperature, pH, pO2pressure

Close loop control Close loop control (physical / chemical(physical / chemical

parameters only)parameters only)

physical / chemicalparameters

Off lineOn line

BiologicalBiologicalProcess ParametersProcess Parameters

New analytictechnology

Advanced Advanced process controlprocess control

QualitativeQualitativequantitativequantitativefingerprintfingerprint

MonitoringMonitoring

hol

dre

lease

Transform to quality data

Product

M

Bioreactor

Process output

Temperature, pH, pO2pressure

Close loop control Close loop control (physical / chemical(physical / chemical

parameters only)parameters only)

physical / chemicalparameters

Off lineOn line

BiologicalBiologicalProcess ParametersProcess Parameters

New analytictechnology

Advanced Advanced process controlprocess control

QualitativeQualitativequantitativequantitativefingerprintfingerprint

MonitoringMonitoring

hol

dre

lease

Transform to quality data

Product

M

Bioreactor

Product

M

Bioreactor